Literature DB >> 11206949

A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states.

X Badia1, M Roset, M Herdman, P Kind.   

Abstract

Few studies have compared preference values for health states obtained in different countries. The present study compared Spanish and United Kingdom (UK) time trade-off values for EuroQol-5D health states. The same preference elicitation protocol was followed in both countries. Differences in values for 43 health states rated directly were analyzed using t tests, and regression coefficients generated by random effects modeling were compared by aggregating the 2 value sets and using dummy variables to analyze country effect by dimension and level of severity. For the milder health states, Spanish and UK value assignation was similar; for intermediate health states, Spanish values were both higher and lower than UK values, whereas for health states worse than death, UK values were generally higher than Spanish values. There were statistically significant differences (P < 0.01) in values for 34.9% of health states rated directly, and some preference reversals between countries. UK raters ascribed greater importance to dimensions of pain/discomfort and anxiety/depression, whereas Spanish raters placed more importance on functional dimensions of mobility and self-care. Further analysis is required to determine how these differences affect cost-effectiveness and cost-utility analyses.

Entities:  

Mesh:

Year:  2001        PMID: 11206949     DOI: 10.1177/0272989X0102100102

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  103 in total

Review 1.  Utility scores for different health states related to depression: individual participant data analysis.

Authors:  Spyros Kolovos; Judith E Bosmans; Johanna M van Dongen; Birre van Esveld; Dorcas Magai; Annemieke van Straten; Christina van der Feltz-Cornelis; Kirsten M van Steenbergen-Weijenburg; Klaas M Huijbregts; Harm van Marwijk; Heleen Riper; Maurits W van Tulder
Journal:  Qual Life Res       Date:  2017-03-04       Impact factor: 4.147

2.  The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries.

Authors:  Raymond Oppong; Billingsley Kaambwa; Jacqueline Nuttall; Kerenza Hood; Richard D Smith; Joanna Coast
Journal:  Eur J Health Econ       Date:  2011-11-05

3.  Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey.

Authors:  Oriol Cunillera; Ricard Tresserras; Luis Rajmil; Gemma Vilagut; Pilar Brugulat; Mike Herdman; Anna Mompart; Antonia Medina; Yolanda Pardo; Jordi Alonso; John Brazier; Montse Ferrer
Journal:  Qual Life Res       Date:  2010-03-31       Impact factor: 4.147

4.  Do Portuguese and UK health state values differ across valuation methods?

Authors:  Lara N Ferreira; Pedro L Ferreira; Donna Rowen; John E Brazier
Journal:  Qual Life Res       Date:  2011-05       Impact factor: 4.147

5.  The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments.

Authors:  Andrea Manca; Mark J Sculpher; Ron Goeree
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

6.  Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer.

Authors:  K Lien; V C Tam; Y J Ko; N Mittmann; M C Cheung; K K W Chan
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

7.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

8.  [Reduction of arthrosis associated knee pain through a single intra-articular injection of synthetic hyaluronic acid].

Authors:  D Krocker; G Matziolis; J Tuischer; J Funk; S Tohtz; F Buttgereit; C Perka
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

9.  US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference?

Authors:  I-Chan Huang; Richard J Willke; Mark J Atkinson; William R Lenderking; Constantine Frangakis; Albert W Wu
Journal:  Qual Life Res       Date:  2007-04-06       Impact factor: 4.147

10.  Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).

Authors:  X Badia; M Roset; E Valassi; H Franz; A Forsythe; S M Webb
Journal:  Qual Life Res       Date:  2013-03-29       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.